Ledger.Open graph →
SEC Form D · filed September 6, 2022

T3D Therapeutics, Inc

Offering
$7.5M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Research Triangle Park, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

John A. Golden · Research Triangle Park, NCDirectorTom A. Mendell · Research Triangle Park, NCDirectorJohn Didsbury · Research Triangle Park, NCExec · Director · PromoterCharles Lineberry · Research Triangle Park, NCDirectorBarry Buzogany · Research Triangle Park, NCDirectorTetsuo Ochi · Hong Kong, Hong KongDirectorCraig N. Snyder · LOS ANGELES, CADirectorDonald Parker · Research Triangle Park, NCDirectorDavid Keim · Research Triangle Park, NCDirectorCharles G. Koch · Wichita, KSDirectorJames B. Hannan · Wichita, KSExec · Director · PromoterRandall A. Bushman · Wichita, KSDirectorMasakatsu J. Hayashi · Hong Kong, Hong KongDirectorRoy H. Markwalter · Atlanta, GADirectorDonald Parker · Research Triangle Park, NCDirectorDavid Keim · Research Triangle Park, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗